ECSP951529A - PHARMACEUTICAL COMPOUNDS - Google Patents
PHARMACEUTICAL COMPOUNDSInfo
- Publication number
- ECSP951529A ECSP951529A ECSP951529A ECSP951529A EC SP951529 A ECSP951529 A EC SP951529A EC SP951529 A ECSP951529 A EC SP951529A EC SP951529 A ECSP951529 A EC SP951529A
- Authority
- EC
- Ecuador
- Prior art keywords
- optionally substituted
- alkyl
- phenyl
- hydrogen
- naphthyl
- Prior art date
Links
Abstract
Un compuesto de la fórmula: en la cual R1 y R7 son cada uno halo, trifluorometilo, alquilo C1-6, alcoxi C1-6, fenilo opcionalmente sustituido, naftilo opcionalmente sustituido o heteroarilo opcionalmente sustituido, R2 y R3 son cada uno hidrógeno o alquilo C1-6, R4 y R5 son cada uno hidrógeno, halo, trifluorometilo, alquilo C1-6, alcoxi C1-6, fenilo opcionalmente sustituido, naftilo opcionalmente sustituido o heteroarilo opcionalmente sustituido, R6 es hidrógeno, alquilo C1-6, fenilo opcionalmente sustituido, naftilo opcionalmente sustituido, heteroarilo opcionalmente sustituido, fenilo C1-6 alquilo opcionalmente sustituido o -CO2R8 donde R8 es un grupo éster, m y p son cada uno 0,1,2,3, o 4, n es 1,2,3 o 4; Z es Donde R9 y R10 son cada uno hidrógeno, alquilo C1-6 o fenilo C1-6 alquilo opcionalmente sustituido, X es oxígeno o azufre y Y es Donde R11 y R12 son cada uno hidrógeno, alquilo C1-6, trifluorometilo, fenilo opcionalmente sustituido, naftilo opcionalmente sustituido o heteroarilo opcionalmente sustituido; y sales y solvatos de los mismos.A compound of the formula: in which R1 and R7 are each halo, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl, R2 and R3 are each hydrogen or alkyl C1-6, R4 and R5 are each hydrogen, halo, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl, R6 is hydrogen, C1-6 alkyl, optionally substituted phenyl , optionally substituted naphthyl, optionally substituted heteroaryl, C1-6 phenyl optionally substituted alkyl or -CO2R8 where R8 is an ester group, m and p are each 0,1,2,3, or 4, n is 1,2,3 or 4 ; Z is Where R9 and R10 are each hydrogen, optionally substituted C1-6 alkyl or phenyl C1-6 alkyl, X is oxygen or sulfur and Y is Where R11 and R12 are each hydrogen, optionally C1-6 alkyl, trifluoromethyl, phenyl substituted, optionally substituted naphthyl or optionally substituted heteroaryl; and salts and solvates thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951529 ECSP951529A (en) | 1995-09-05 | 1995-09-05 | PHARMACEUTICAL COMPOUNDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951529 ECSP951529A (en) | 1995-09-05 | 1995-09-05 | PHARMACEUTICAL COMPOUNDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP951529A true ECSP951529A (en) | 1997-05-16 |
Family
ID=42042171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP951529 ECSP951529A (en) | 1995-09-05 | 1995-09-05 | PHARMACEUTICAL COMPOUNDS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP951529A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11130755B2 (en) | 2016-11-07 | 2021-09-28 | Sanofi | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders |
-
1995
- 1995-09-05 EC ECSP951529 patent/ECSP951529A/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11130755B2 (en) | 2016-11-07 | 2021-09-28 | Sanofi | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders |
| US11827633B2 (en) | 2016-11-07 | 2023-11-28 | Sanofi | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY132009A (en) | Pharmaceutical compounds. | |
| CO5050332A1 (en) | FUNGICIDE COMPOSITIONS THAT INCLUDE 2-METOXIBENZOPHENONES | |
| CO4970713A1 (en) | DERIVATIVES OF CARBOXAMIDOTIAZOLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| GB9423968D0 (en) | Resolution | |
| FI954105A (en) | New 4-aminopyridines, process for their preparation and compounds containing them | |
| DK633088A (en) | collagenase | |
| PT1140916E (en) | CYCLE HETEROARIL ACETIS | |
| SE0101579D0 (en) | New compounds | |
| DE69728544D1 (en) | TOTAL SYNTHESIS OF ACYL FULVENES WITH ANTITUARY EFFECT | |
| ES2177058T3 (en) | ETER PIPERIDINYLAMINOMETIL TRIFLUOROMETIL CYCLES COMPOUNDS AS AN SUBGONIST OF THE SUBSTANCE P. | |
| DE69206274T2 (en) | 3-UREIDO-BENZODIAZEPINONE CAN BE USED AS CCK OR GASTRIN ANTAGONISTS. | |
| HRP20000508B1 (en) | Substituted 2-benzylamino-2-phenyl-acetamide compounds | |
| ES2058531T3 (en) | MERCAPTO-PHENYLALCANOYLAMINO ACIDS AMIDES, THEIR PREPARATION AND THEIR USE AS COLLAGENASE INHIBITORS. | |
| FI834730A0 (en) | 1-CARBOXYKANOYLPERHYDRO-INDOL-2-CARBOXYLSYROR OR DERIVATIVES | |
| ECSP951529A (en) | PHARMACEUTICAL COMPOUNDS | |
| CO5011110A1 (en) | NEW DERIVATIVES OF 2- (3H) -OXAZOLONA | |
| DK0816358T3 (en) | 4-Amino-2-ureidopyrimidine-5-carboxylic acid amides, process for their preparation, drugs containing such compounds and their use | |
| DK0435235T3 (en) | New isoquinoline derivatives and salts thereof | |
| BR9812928A (en) | New 3-oxo- (2h) -1,2,4-triazine derivatives, process for preparing chemical compounds, and pharmaceutical composition | |
| ATE148462T1 (en) | ISOXAZOLE DERIVATIVES AS LIGHT PROTECTIVE AGENTS | |
| ES2192342T3 (en) | 2- (2,6-DIOXO-3-FLUOROPIPERIDIN-3-IL) -ISOINDOLINAS REPLACED AND ITS USE TO REDUCE TNFALFA LEVELS. | |
| CO4480027A1 (en) | TETRAHIDROPIRIDOINDOLIL BENZIMIDAZOLONAS AND ITS USE AS A PHARMACEUTICAL | |
| ES2059928T3 (en) | CYCLOPROPANOTIOCARBOXIAMIDES. | |
| ES2120885A1 (en) | New thienopyrimidones with antifungal activity | |
| MY101878A (en) | 1,3,4-thiadiazole |